Surmodics Inc (SRDX)
39.33
+0.14
(+0.36%)
USD |
NASDAQ |
Nov 22, 16:00
39.28
-0.05
(-0.13%)
After-Hours: 20:00
Surmodics Enterprise Value: 552.88M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 552.88M |
| November 21, 2024 | 550.88M |
| November 20, 2024 | 550.59M |
| November 19, 2024 | 550.88M |
| November 18, 2024 | 551.74M |
| November 15, 2024 | 544.14M |
| November 14, 2024 | 535.08M |
| November 13, 2024 | 536.23M |
| November 12, 2024 | 541.81M |
| November 11, 2024 | 540.67M |
| November 08, 2024 | 540.38M |
| November 07, 2024 | 539.52M |
| November 06, 2024 | 540.81M |
| November 05, 2024 | 528.92M |
| November 04, 2024 | 527.63M |
| November 01, 2024 | 528.49M |
| October 31, 2024 | 526.92M |
| October 30, 2024 | 526.63M |
| October 29, 2024 | 526.77M |
| October 28, 2024 | 530.93M |
| October 25, 2024 | 527.92M |
| October 24, 2024 | 535.65M |
| October 23, 2024 | 537.80M |
| October 22, 2024 | 537.80M |
| October 21, 2024 | 539.67M |
| Date | Value |
|---|---|
| October 18, 2024 | 537.52M |
| October 17, 2024 | 539.24M |
| October 16, 2024 | 541.38M |
| October 15, 2024 | 541.67M |
| October 14, 2024 | 538.38M |
| October 11, 2024 | 541.96M |
| October 10, 2024 | 543.25M |
| October 09, 2024 | 541.67M |
| October 08, 2024 | 536.66M |
| October 07, 2024 | 537.52M |
| October 04, 2024 | 539.81M |
| October 03, 2024 | 536.66M |
| October 02, 2024 | 539.09M |
| October 01, 2024 | 539.67M |
| September 30, 2024 | 544.97M |
| September 27, 2024 | 540.48M |
| September 26, 2024 | 540.19M |
| September 25, 2024 | 545.33M |
| September 24, 2024 | 549.47M |
| September 23, 2024 | 552.61M |
| September 20, 2024 | 551.46M |
| September 19, 2024 | 553.46M |
| September 18, 2024 | 552.04M |
| September 17, 2024 | 551.46M |
| September 16, 2024 | 554.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
245.03M
Minimum
Mar 23 2023
771.71M
Maximum
Nov 08 2021
515.53M
Average
503.15M
Median
Jun 04 2020
Enterprise Value Benchmarks
| Baxter International Inc | 28.54B |
| Boston Scientific Corp | 141.27B |
| Globus Medical Inc | 11.28B |
| Perspective Therapeutics Inc | -31.63M |
| Electromed Inc | 238.10M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.449M |
| Revenue (Quarterly) | 33.23M |
| Total Expenses (Quarterly) | 33.84M |
| EPS Diluted (Quarterly) | -0.24 |
| Gross Profit Margin (Quarterly) | 44.70% |
| Profit Margin (Quarterly) | -10.38% |
| Earnings Yield | -2.06% |
| Normalized Earnings Yield | -2.298 |